Skip to main content

Table 1 Baseline characteristics of patients at the start of high-volume hemofiltration

From: Sublingual microcirculatory changes during high-volume hemofiltration in hyperdynamic septic shock patients

Patient

Diagnosis

APACHE II score

SOFA score

Survival

(day 28)

MAP,

mm Hg

NE dose, μg/kg per min

CI,

L/min per m2

SmvO2,

percentage

Lactate, mmol/L

1

Cholangitis

34

13

Yes

70

0.30

3

49

6

2

Necrotizing fasceitis

24

10

Yes

67

0.56

5.5

79

4.7

3

Cholangitis

25

11

Yes

65

0.50

5.3

76

8.3

4

Catheter related sepsis

31

15

No

70

0.60

3.1

71

4.1

5

Diverticulitis

19

14

Yes

75

0.37

5.5

80

2.6

6

Peritonitis

19

11

No

64

0.30

4.4

61

6.7

7

Pneumonia

21

13

Yes

74

0.50

3.1

58

2.6

8

Necrotizing fasceitis

25

13

No

64

1.00

4.8

79

4.5

9

Pyonephrosis

23

13

Yes

66

0.28

3.5

71

3.6

10

Mesenteric ischemia

23

13

Yes

62

0.62

3.4

78

2.6

11

Empyema

27

14

No

63

0.30

4.8

96

13

12

Endocarditis

25

15

No

70

0.60

3

70

5.8

Mean

 

24.7

12.8

 

67.5

0.49

4.1

72

5.4

SD

 

4.4

1.7

 

4.3

0.21

1.0

11

3.0

  1. APACHE II, Acute Physiology and Chronic Health Evaluation II; CI, cardiac index; MAP, mean arterial pressure; NE, norepinephrine; SD, standard deviation; SmvO2, mixed venous oxygen saturation; SOFA, Sequential Organ Failure Assessment.